Anticonvulsant activity of topiramate and phenytoin in a rat model of ischaemia-induced epilepsy

Life Sciences

Volumn 59, Issue 10, 1996, Pages

  Edmonds Jr , Harvey L ^a   Jiang, Yi D ^a   Zhang, Ping Y ^a   Shank, Richard P ^b  

^a University of Louisville School of Medicine   (United States)

^b R W JOHNSON PHARMACEUTICAL RES I   (United States)

Author keywords

Anticonvulsant; Cerebral ischemia; Epilepsy; Phenytoin; Topiramate

Indexed keywords

ANTICONVULSIVE AGENT; NEW DRUG; PHENYTOIN; TOPIRAMATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; AUDIOGENIC SEIZURE; BRAIN ISCHEMIA; CLONIC SEIZURE; CONTROLLED STUDY; DISEASE SEVERITY; EPILEPSY; MALE; NEUROLOGIC DISEASE; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; RUNNING; TONIC SEIZURE;

ANIMALIA;

EID: 0344625216     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00379-7     Document Type: Article

References (18)

1. 1. P.C. JOBE, Drugs for Control of Epilepsy. Faingold, C.L. and Fromm, G.H. (Eds.), CRC Press: Boca Raton, pp. 253-275 (1992).
2. 2. C.L. FAINGOLD and D.K. NARITOKU, Drugs for Control of Epilepsy, Faingold, C.L. and Fromm, G.H. (Eds.), CRC Press: Boca Raton, pp. 277-308 (1992).
3. 3. V. IYER, K.H. REID, A. SCHURR, L.A. CARR, M.T. TSENG and J.J. MILLER, Soc. Neurosci. Abstr. 21 1961 (1995).
4. 4. KAWAI, K., L.P. PENIX and I. KLATZO, Epilepsia 33 (S3) 38 (1992).
5. 5. K. H. REID, V. IYER, and A. SCHURR, Fed. Proc. 8 A660 (1994).
6. 6. WAUQUIER A., W. MELIS, and P.A.J. JANSSEN, Neuropharmacology 28 837-846 (1989).
7. 7. J.F. ANNEGERS, The Treatment of Epilepsy: Principles and Practices, Wyllie, E. (Ed.), Lea & Febiger: Philadelphia, pp. 157-164 (1993).
8. 8. J.W. NEWBURGER, R.A. JONAS, G. WERNOVSKY, et. al., New Engl J Med 329 1057-1064 (1993).
9. 9. H.L. EDMONDS JR., G.M. RAQUE JR., Y.P. ZHANG et. al., Cerebral Ischemia and Calcium, Kuchinsky, W. and Hartmann, A. (Eds), Springer-Verlaag, Berlin, pp. 494-500 (1989).
10. 10. E. FAUGHT, B.J. WILDER, R.E. RAMSEY, R.A. REIFE, L D. KRAMER, G.W. PLEDGER, R.M. KARIM et. al., Epilepsia 36 (S4) 33 (1995).
11. 11. S.K. SACHDEO, R.C. SACHDEO, R.A. REIFE, P. LIM and G. PLEDGER, Epilepsia 36 (S4) 33 (1995).
12. 12. H.S. WHITE, S.D. BROWN, G.A. SKEEN, and R.E. TWYMAN, Epilepsia 36 (S4) 34 (1995).
13. 13. L. SEVERT, J. W. GIBBS III, D.A. COULTER, S. SOMBATI and R.J. DELORENZO, Epilepsia 36 (S4) 38 (1995).
14. 14. S. SOMBATI, D.A. COULTER and R.J. DELORENZO, Epilepsia 36 (S4) 38 (1995).
15. 15. R.P. SHANK, J.F. GARDOCKI, J.L. VAUGHT, C.B. DAVIS, J.J. SCHUPSKY, R.B. RAFFA, S.J. DODGSON, S.O. NORTEY, and B.E. MARYANOFF, Epilepsia 35 450-460 (1994).
16. 16. K. TANABE, Y. WANG and K. KIMISHIMA, J. Yonago Medical Assoc. 42 330-346 (1991).
17. 17. J. NAKAMURA, S. TAMURA, T. KANDA, A. ISHII, K. ISHIHARA, T. SERIKAWA, J. YAMADA, and M. SASA, Eur. J. Pharmacol. 254 83-89 (1994).
18. 18. A. WAUQUIER and S. ZHOU, Epilepsy Res. 23 (in press)